Taken together, these observations highlight the putative role of RAC3 as a central modulator of the proliferative, invasive, and metastatic activities of bladder cancer, suggesting its potential as a novel therapeutic target for BLCA. The gene discussed is RAC3; the disease is bladder transitional cell carcinoma.